1 | network across 5 continents | | | | | | | 3 | 0.46% |
2 | distribution network across 5 | | | | | | | 3 | 0.46% |
3 | investments within medtech sector | | | | | | | 2 | 0.31% |
4 | wide distribution network across | | | | | | | 2 | 0.31% |
5 | innovative solutions and products | | | | | | | 2 | 0.31% |
6 | key role in an | | | | | | | 1 | 0.15% |
7 | modular walls medical ceilings | | | | | | | 1 | 0.15% |
8 | integration systems and mobile | | | | | | | 1 | 0.15% |
9 | responsible mainly for investments | | | | | | | 1 | 0.15% |
10 | mainly for investments within | | | | | | | 1 | 0.15% |
11 | goals build a powerful | | | | | | | 1 | 0.15% |
12 | scrub sinks medical cabinets | | | | | | | 1 | 0.15% |
13 | lights scrub sinks medical | | | | | | | 1 | 0.15% |
14 | tables lights scrub sinks | | | | | | | 1 | 0.15% |
15 | operating tables lights scrub | | | | | | | 1 | 0.15% |
16 | windows operating tables lights | | | | | | | 1 | 0.15% |
17 | for investments within industrial | | | | | | | 1 | 0.15% |
18 | walls medical ceilings medical | | | | | | | 1 | 0.15% |
19 | includes modular walls medical | | | | | | | 1 | 0.15% |
20 | and mobile hospitals wwwalvopl | | | | | | | 1 | 0.15% |
21 | a key role in | | | | | | | 1 | 0.15% |
22 | healthcare science research microelectronics | | | | | | | 1 | 0.15% |
23 | science research microelectronics automotive | | | | | | | 1 | 0.15% |
24 | portfolio includes modular walls | | | | | | | 1 | 0.15% |
25 | product portfolio includes modular | | | | | | | 1 | 0.15% |
26 | sector jan izÁk cfo | | | | | | | 1 | 0.15% |
27 | jan izÁk cfo of | | | | | | | 1 | 0.15% |
28 | in modular solutions installed | | | | | | | 1 | 0.15% |
29 | sqm in modular solutions | | | | | | | 1 | 0.15% |
30 | of sqm in modular | | | | | | | 1 | 0.15% |
31 | thousand of sqm in | | | | | | | 1 | 0.15% |
32 | systems and mobile hospitals | | | | | | | 1 | 0.15% |
33 | mobile hospitals wwwalvopl block | | | | | | | 1 | 0.15% |
34 | role in an international | | | | | | | 1 | 0.15% |
35 | clean room solutions such | | | | | | | 1 | 0.15% |
36 | for the pharmaceutical biotechnological | | | | | | | 1 | 0.15% |
37 | projects for the pharmaceutical | | | | | | | 1 | 0.15% |
38 | provides projects for the | | | | | | | 1 | 0.15% |
39 | company provides projects for | | | | | | | 1 | 0.15% |
40 | in an international expansion | | | | | | | 1 | 0.15% |